Across the recent three months, 5 analysts have shared their insights on Roivant Sciences (NASDAQ:ROIV), expressing a variety of opinions spanning from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $16.9, a high estimate of $18.00, and a low estimate of $12.50. This upward trend is apparent, with the current average reflecting a 0.6% increase from the previous average price target of $16.80.

Investigating Analyst Ratings: An Elaborate Study

A...